CYTORI THERAPEUTICS, INC. Business Finance Contracts & Agreements
114 Contracts & Agreements
- Investment Agreements (1 contract)
- Loan Agreements (21)
- Note Agreements (4)
- Pledge Agreements (1)
- Purchase Agreements (16)
- Registration Rights Agreements (6)
- Release Agreements (2)
- Repurchase Agreements (1)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (21)
- Subscription Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (32)
- Registration Rights Agreement, dated as of May 5, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)
- First Amendment to Securities Purchase Agreement, dated as of May 8, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)
- Securities Purchase Agreement, dated as of May 5, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)
- Form of Series B Warrant (Filed With SEC on May 9, 2024)
- Form of Series A Warrant (Filed With SEC on May 9, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on May 9, 2024)
- Ten Amendment to Loan and Security Agreement, dated June 28, 2023, by and among Plus Therapeutics, Inc., Oxford Finance, LLC and lenders listed thereof (Filed With SEC on March 5, 2024)
- Tenth Amendment to Loan and Security Agreement (Filed With SEC on August 14, 2023)
- Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto (Filed With SEC on March 3, 2023)
- Registration Rights Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)
- Purchase Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)
- Registration Rights Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)
- Purchase Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)
- Form of Underwriter Warrant Amendment Agreement (Filed With SEC on October 5, 2020)
- Form of Warrant Amendment Agreement (Filed With SEC on April 23, 2020)
- Ninth Amendment to the Loan and Security Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and Oxford Finance LLC (Filed With SEC on March 30, 2020)
- Form of Series V Warrant (Filed With SEC on September 16, 2019)
- Form of Series U Warrant (Filed With SEC on September 16, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 16, 2019)
- Eighth Amendment to Loan and Security Agreement, effective as of July 15, 2019, by and between Plus Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)
- Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)
- Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on May 14, 2019)
- Asset and Share Sale and Purchase Agreement, dated as of April 19, 2019, by and between Cytori Therapeutics, Inc. and Seijir Shirahama (Filed With SEC on April 23, 2019)
- Sixth Amendment to Loan and Security Agreement dated March 4, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)
- Fifth Amendment to Loan and Security Agreement dated February 13, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)
- Fourth Amendment to Loan and Security Agreement dated December 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on February 1, 2019)
- Third Amendment to Loan and Security Agreement, dated August 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on September 21, 2018)
- Second Amendment to Loan and Security Agreement, dated June 19, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 14, 2018)
- Form of Common Stock Certificate (Filed With SEC on March 9, 2018)
- RESTATED WARRANT AGENT AGREEMENT (Filed With SEC on August 11, 2017)
- COMMON STOCKPURCHASE WARRANT CYTORI THERAPEUTICS, INC. (Filed With SEC on April 12, 2017)
- CYTORI THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2017)
- ASSET PURCHASE AGREEMENT by and between Cytori Therapeutics, Inc. and Azaya Therapeutics, Inc. January 16, 2017 TABLE OF CONTENTS (Filed With SEC on March 24, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2016)
- PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)
- WARRANT AGENT AGREEMENT (Filed With SEC on May 11, 2016)
- [Form of Warrant Certificate] [FACE] (Filed With SEC on May 11, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on May 11, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on April 6, 2016)
- Amendment One to the Securities Purchase Agreement between the Company and certain institutional investors dated May 5, 2015 (Filed With SEC on March 11, 2016)
